Suzuki T, Shiraishi T, Tomita K, Totani M, Murachi T
Biochemistry Department, Research and Development Center, Unitika, Ltd, Kyoto, Japan.
Clin Chem. 1990 Jan;36(1):153-6.
Monoclonal antibody CKM-G01 inhibited greater than 99% of the activity of porcine and human creatine kinase(CK)-MM isoenzyme purified from muscle. However, it inhibited only 54% of CK-MM in human serum. Chromatofocusing of serum CK-MM showed that CKM-G01 inhibited 100% of MM3 but not isoform MM1. CKM-G01 inhibited CK-MM2 by 57%. CKM-G01 specifically inhibited only the original CK-M subunit and not the subunit modified by removal of C-terminal lysine by carboxypeptidase N. CKM-G01 can be used for assay of CK isoforms. We devised a new diagnostic reagent involving it, which requires no analytical separation of isoforms, based on the immunoinhibition method, and applied it to early diagnosis of acute myocardial infarction. The "inhibition index," (inhibited CK activity/total CK activity) x 100, increased more rapidly than did total CK and CK-MB. Evidently this diagnostic reagent can be used for easy, early diagnosis of acute myocardial infarction.
单克隆抗体CKM-G01可抑制从肌肉中纯化的猪和人肌酸激酶(CK)-MM同工酶活性的99%以上。然而,它仅抑制人血清中54%的CK-MM。血清CK-MM的色谱聚焦显示,CKM-G01可100%抑制MM3,但不抑制MM1同工型。CKM-G01可抑制57%的CK-MM2。CKM-G01仅特异性抑制原始的CK-M亚基,而不抑制经羧肽酶N去除C末端赖氨酸修饰的亚基。CKM-G01可用于CK同工型的检测。我们基于免疫抑制法设计了一种包含它的新型诊断试剂,该试剂无需对同工型进行分析分离,并将其应用于急性心肌梗死的早期诊断。“抑制指数”[(抑制的CK活性/总CK活性)×100]比总CK和CK-MB升高得更快。显然,这种诊断试剂可用于急性心肌梗死的简便、早期诊断。